Foster youth and psychotropic treatment: Where next?

Children and Youth Services Review

Volumn 33, Issue 2, 2011, Pages 395-404

  Longhofer, Jeffrey ^a   Floersch, Jerry ^a   Okpych, Nate ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Explanatory models; Foster care; Practice arbitrage; Psychotropic medication; Treatment parameter illness behavior

Indexed keywords

EID: 78650304741     PISSN: 01907409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.childyouth.2010.10.006     Document Type: Article

References (173)

1. A.B. 82, Cal. Com. Code Section 369.6 (2009).
2. Allen B., Vacca J.S. Frequent moving has a negative affect on the school achievement of foster children makes the case for reform. Children & Youth Services Review 2010, 32:829-832.
3. Applbaum K. 'Consumers are patients!' shared decision-making and treatment non-compliance as business opportunity. Transcultural Psychiatry 2009, 46(1):107-130.
4. Aram J.D., Salipante P.F. Bridging scholarship in management: Epistemological reflections. British Journal of Management 2003, 14(3):189-205.
5. Arnd-Caddigan M., Pozzuto R. Types of knowledge, forms of practice. The Qualitative Report 2008, 13(1):61-77.
6. Azevedo J. Mapping reality: An evolutionary realist methodology for the natural an social sciences 1997, State University of New York Press, Albany, NY.
7. Baer R.D., Weller S.C., de Alba García J.G., Salcedo Rocha A.L. Cross-Cultural perspectives on physician and lay models of the common cold. Medical Anthropology Quarterly 2008, 22(2):148-166.
8. Barbell K., Freundlich M. Foster care today 2001, Casey Family Programs, Washington, D.C.
9. Barber J.G., Delfabbro P.H., Cooper L.L. The predictors of unsuccessful transition to foster care. Journal of Child Psychology and Psychiatry 2001, 42:785-790.
10. Bellefeuille G., Ricks F. Relational inquiry: A child and youth care approach to research. Children and Youth Services Review 2010, 32:1235-1241.
11. Beutler L.E., Howard K.I. Clinical utility research: An introduction. Journal of Clinical Psychology 1998, 54:297-301.
12. Bhaskar R. The possibility of naturalism: A philosophical critique of the contemporary human sciences 1998, Routledge, New York. 3rd ed.
13. Biehl J. Life of the mind: The interface of psychopharmaceuticals, domestic economies, and social abandonment. American Ethnologist 2004, 31(4):475-496.
14. Biehl J.G. Vita: Life in a zone of social abandonment 2005, University of California Press, Berkeley.
15. Bonati M., Clavenna A. The epidemiology of psychotropic drug use in children and adolescents. International Review of Psychiatry 2005, 17:181-188.
16. Boss P. Ambiguous loss 1999, Harvard University Press, Cambridge, MA.
17. Boss P. Ambiguous loss research, theory, and practice: Reflections after 9/11. Journal of Marriage & Family Therapy 2004, 66:551-566.
18. Bourdieu P. The Logic of Practice 1990, Polity Press, Cambridge.
19. Bourdieu P. Practical Reason: On the Theory of Action 1998, Stanford University Press, Stanford.
20. Bourdieu P., Wacquant L. An invitation to reflexive sociology 1992, University of Chicago Press, Chicago.
21. Bowlby J. Attachment and loss 1969, Vol. 1. Basic Books, New York.
22. Bowlby J. Attachment and loss 1973, Vol. 2. Basic Books, New York.
23. Boyer E.L. Scholarship reconsidered: Priorities of the professoriate 1990, The Carnegie Foundation for the Advancement of Teaching, New York.
24. Burns B.J., Phillips S.D., Wagner H.D. Mental health need and access to mental health services by youths involved with child welfare: A national survey. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:960-970.
25. Carlson V., Cicchetti D., Barnett D., Braunwald K. Disorganized/disoriented attachment relationships in maltreated infants. Developmental Psychology 1989, 25:525-531.
26. Carpenter-Song E. Children's sense of self in relation to clinical processes: Portraits of pharmaceutical transformation. Ethos 2009, 37:257-281.
27. Carroll K.M., Rounsaville B.J. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatric Services 2003, 54:333-339.
28. Cicchetti D., Toth S.L. A developmental psychopathology perspective on child abuse and neglect. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:541-565.
29. Collier A. Critical realism: An introduction to Roy Bhaskar's philosophy 1994, Verso Press, London.
30. Connell C.M., Vanderploeg J.J., Flaspohler P., Katz K.H., Saunders L., Tebes J.K. Changes in placement among children in foster care: A longitudinal study of child and case influences. The Social Service Review 2006, 80:398-418.
31. Correll C.U. Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:9-20.
32. Correll C.U., Carlson H.E. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:771-791.
33. Corrigan P. How stigma interferes with mental health care. The American Psychologist 2004, 59:614-625.
34. Costa L.G., Steardo L., Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: Experimental and clinical aspects. Pharmacological Reviews 2004, 56:103-137.
35. Crismon M.L., Argo T. The use of psychotropic medication for children in foster care. Child Welfare 2009, 88:71-100.
36. Crocker J., Garcia J.A. Stigma and the social basis of the self: A synthesis. Stigma and group inequality: Social psychological perspectives 2006, 287-308. Erlbaum Associates, New York. S. Levin, C. van Laar (Eds.).
37. Crocker J., Wolfe C.T. Contingencies of self-worth. Psychological Review 2001, 108:593-623.
38. Crystal S., Olfson M., Huang C., Pincus H., Gerhard T. Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs 2009, 28:770-781.
39. Daley T., Weisner T. "I speak a different dialect": Teen explanatory models of difference and disability. Medical Anthropology Quarterly 2003, 17(1):25-48.
40. De Civita M., Dobkin P.L. Pediatric adherence as a multidimensional and dynamic construct, involving a triadic partnership. Journal of Pediatric Psychology 2004, 29:157-169.
41. DeVeaugh-Geiss J., March J., Shapiro M., Andreason P.J., Emslie G., Ford, et al. Child and adolescent psychopharmachology in the new millennium: A workshop for academia, industry, and government. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:261-270.
42. DiGiuseppe D.L., Christakis D.A. Continuity of care for children in foster care. Pediatrics 2003, 111:e208.
43. dosReis S., Zito J.M., Safer D.J., Gardner J.F., Puccia K.B., Owens P.L. Multiple psychotropic medication use for youths: A two-state comparison. Journal of Child and Adolescent Psychopharmacology 2005, 15:68-77.
44. dosReis S., Zito J.M., Safer D.J., Soeken K.L. Mental health services for youths in foster care and disabled youths. American Journal of Public Health 2001, 91:1094-1099.
45. Dozier M., Higley E., Albus K.E., Nutter A. Intervening with foster infants' caregivers: Targeting three critical needs. Infant Mental Health Journal 2002, 23:541-554.
46. Dozier M., Stovall K.C., Albus K.E., Bates B. Attachment for infants in foster care: The role of caregiver state of mind. Child Development 2001, 72:1467-1477.
47. Fanshel D., Finch S.J., Grundy J.F. Modes of exit from foster family care and adjustment at time of departure of children with unstable life histories. Child Welfare 1989, 68:391-402.
48. Farmer E.M., Mustillo S.A., Wagner H.R., Burns B.J., Kolko D.J., Barth R.P., et al. Service use and multi-sector use for mental health problems by youth in contact with child welfare. Children & Youth Services Review 2010, 32:815-821.
49. Fernandez E. Pathways in substitute care: Representation of placement careers of children using event history analysis. Children & Youth Services Review 1999, 21:177-216.
50. Fla. Stat. §39.407 (2006).
51. Floersch J. The subjective experience of youth psychotropic experience. Social Work in Mental Health 2003, 1(4):51-69.
52. Floersch J., Longhofer J., Kranke D., Townsend L. Integrating thematic, grounded theory, and narrative analysis: A case study of adolescent psychotropic treatment. Qualitative Social Work 2010, 9:407-425.
53. Floersch J., Townsend L., Longhofer J., Munson M., Winbush V., Kranke D., et al. Adolescent experience of psychotropic treatment. Transcultural Psychiatry 2009, 46:157-179.
54. Florida Department of Children & Families Report of Gabriel Myers workgroup 2009, November 19, Retrieved from http://www.dcf.state.fl.us/initiatives/GMWorkgroup/index.shtml.
55. Garro L.C. Explaining high blood pressure: Variation in knowledge about illness. American Ethnologist 1988, 15(1):98-119.
56. Garro L.C. Cultural meaning, explanations of illness, and the development of comparative frameworks. Ethnology 2000, 39(4):305-334.
57. George C., Main M. Social interactions of young abused children: Approach, avoidance, and aggression. Child Development 1979, 50:306-318.
58. Gould M.S., Walsh B.T., Munfakh J.L., Kleinman M., Doan N., Olfson M., Greenhill L., Cooper T. Sudden death and use of stimulant medications in youths. American Journal of Psychiatry 2009, 166:992-1001.
59. Greenhill L.J., Vitiello B., Riddle M.A. Review of safety assessment methods used in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42:627-633.
60. Groleau D., Kirmayer L., Young A. The McGill Illness Narrative Interview (MINI): An interview schedule to explore different meanings and modes of reasoning related to illness experience. Transcultural Psychiatry 2006, 43(4):697-717.
61. H.B. 3114, 75 ORS Section 418.517 (2009). http://www.leg.state.or.us/09reg/measpdf/hb3100.dir/hb3114.en.pdf.
62. Hagen S., Orbeck L.A. The prescription of psychotropic medications in foster care children: A descriptive study in St. Louis county 2006, Retrieved from http://www.d.umn.edu/sw/executive/hstacy.html.
63. Harman J.S., Childs G., Kelleher K.J. Mental health care utilization and expenditures by children in foster care in southwestern Pennsylvania. Archives of Pediatrics & Adolescent Medicine 2000, 154:1114-1117.
64. Hinshaw S.P. The stigmatization of mental illness in children and parents: Developmental issues, family concerns, and research needs. Journal of Child Psychology and Psychiatry 2005, 46:714-734.
65. Hochman G., Hochman A., Miller J. Foster care: Voices from the inside Retrieved from the Pew Commission on Children in Foster Care. http://pewfostercare.org/research/voices/voices-complete.pdf.
66. Huff A.S. 1999 presidential address: Changes in organizational knowledge production. Academy of Management Review 2000, 25:288-293.
67. Hyde J., Kammerer N. Adolescents' perspectives on placement moves and congregate settings: Complex and cumulative instabilities. Children & Youth Services Review 2008, 31:265-273.
68. Invest in KIDS Act, 110 H.R. § 5466 (2008).
69. Jackson D. As bipolar diagnoses in foster children rise, informed consent becomes a bygone. Chicago Tribune 2009, December 10, Retrieved from http://articles.chicagotribune.com/2009-12-10/news/chi-psychotropic-sidedec10_1_psychotropic-illinois-wards-consent.
70. James S. Why do foster care placements disrupt? An investigation of reasons for placement change in foster care. The Social Service Review 2004, 78:601-627.
71. James S., Landsverk J., Slymen D.J. Placement movement in out-of-home care: Patterns and predictors. Children & Youth Services Review 2004, 26:185-206.
72. Jensen P.S., Bhatara V.S., Vitiello B., Hoagwood K., Feil M., Burke L.B. Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry 1999, 38:557-565.
73. Jensen P.S., Knapp P., Mrazek D.A. Toward a new diagnostic system for child psychopathology: Moving beyond the DSM 2006, The Guilford Press, New York.
74. Jerrell J.M., Hwang T.L., Livingston T.S. Neurological adverse events associated with antipsychotic treatment in children and adolescents. Journal of Child Neurology 2008, 23:1392-1399.
75. Kimberlin S.E., Anthony E.K., Austin M.J. Re-entering foster care: Trends, evidence and implications. Children & Youth Services Review 2008, 31:471-481.
76. Kirmayer L. Cultural variations in the clinical presentation of depression and anxiety: Implications for diagnosis and treatment. Journal of Clinical Psychiatry 2001, 62(Supplement 13):22-28.
77. Kirmayer L.J. Culture, context and experience in psychiatric diagnosis. Psychopathology 2005, 38:192-196.
78. Kleinman A. The illness narratives: Suffering, healing, and the human condition 1988, Basic Books, New York.
79. Koh E. Permanency outcomes of children in kinship and non-kinship foster care: Testing the external validity of kinship effects. Children & Youth Services Review 2010, 32:389-398.
80. Kools S. Self-protection in adolescents in foster care. Journal of Child and Adolescent Psychiatric Nursing 1999, 12:139-152.
81. Kranke D., Floersch J., Townsend L., Munson M. Stigma experience among adolescents taking psychiatric medication. Child & Youth Services Review 2009, 32:496-505.
82. Leslie L.K., Landsverk J.L., Ezzet-Lofstrom R. Children in foster care: Factors influencing outpatient mental health service use. Child Abuse & Neglect 2000, 24:465-476.
83. Leslie L.K., Mackie T., Dawson E.H., Bellonci C., Schoonover D.R., Rodday A.M., et al. Multi-state study on psychotropic medication oversight in foster care 2010, Tufts Clinical Translational Science Institute, Boston, MA.
84. Longhofer J., Floersch J. The phenomenological practice gap: Practice guidelines, evaluation, and clinical judgment. Qualitative Social Work 2004, 3(4):483-486.
85. Longhofer J., Floersch J. Desire and disappointment: Adolescent psychotropic treatment and adherence. Anthropology and Medicine 2010, 17(2):159-172.
86. Longhofer J., Floersch J., Jenkins J.H. The social grid of community medication management. The American Journal of Orthopsychiatry 2003, 73(1):24-34.
87. Longhofer J., Floersch J., Jenkins J.H. Medication effect interpretation and the social grid of management. Social Work in Mental Health 2004, 1(4):71-89.
88. Longhofer J., Kubek P., Floersch J. On being and having a case manager: A relational approach to recovery in mental health 2010, Columbia University Press, New York.
89. Luby J., Mrakotsky C., Stalets M.M., Belden A., Heffelfinger A., Williams M., et al. Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. Journal of Child and Adolescent Psychopharmacology 2006, 16:575-587.
90. Main M., Solomon J. Procedures for identifying infants as disorganized/disoriented during the Ainsworth strange situation. Attachment during the preschool years (121-160) 1990, University of Chicago Press. M. Greenberg, D. Cicchetti, E.M. Cummings (Eds.).
91. Malone R., Sheikh R., Zito J. Novel antipsychotic medications in the treatment of children and adolescents. Psychiatric Services 1999, 50(2):171-174.
92. McIntyre A., Keesler T.Y. Psychological disorders among foster children. Journal of Clinical Child Psychology 1986, 15:297-303.
93. McMillen J.C., Scott L.D., Zima B.T., Ollie M.T., Munson M.R., Spitznagel E. Use of mental health services among older youth in foster care. Psychiatric Services 2004, 55:811-817.
94. Miller C.M. Child-welfare panel: Drugs misused on foster kids. Miami Herald 2009, August 12, Retrieved from http://www.miamiherald.com/2009/08/12/1183698_child-welfare-panel-drugs-misused.html.
95. Mitchell M.B., Kuczynski L. Does anyone know what is going on? Examining children's lived experience of the transition into foster care. Children & Youth Services Review 2010, 32:437-444.
96. Mojtabai R., Olfson M. National trends in psychotherapy by office-based psychiatrists. Archives of General Psychiatry 2008, 65:962-970.
97. Mojtabai R., Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry 2010, 67:26-36.
98. Molin R., Palmer S. Consent and participation: Ethical issues in the treatment of children in out-of-home care. The American Journal of Orthopsychiatry 2005, 75:152-157.
99. Moses T. Psychotropic medication practices for youth in systems of care. Journal of Child and Family Studies 2008, 17:567-581.
100. Mueller E., Silverman N. Peer relations in maltreated children. Child maltreatment: Theory and research on the causes and consequences of child abuse and neglect 1989, 529-578. Cambridge University Press, New York. D. Cicchetti, V. Carlson (Eds.).
101. N.Y. U.C.C. Bill Section 208.227 Draft (2010).
102. Naylor M.W., Davidson C.V., Ortega-Piron D., Bass A., Gutierrez A., Hall A. Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations. Child Welfare 2007, 86:175-192.
103. Newton R.R., Litrownik A.J., Landsverk J.A. Children and youth in foster care: Disentangling the relationship between problem behaviors and number of placements. Child Abuse & Neglect 2000, 24:1363-1374.
104. Norquist G., Lebowitz B., Hyman S. Expanding the frontier of treatment research. Prevention & Treatment 1999, 2. n.p.
105. Oldani M.J. Uncanny scripts: Understanding pharmaceutical emplotment in the aboriginal context. Transcultural Psychiatry 2009, 461(1):131-156.
106. No child left different 2006, Praeger Publishers, Westport, CT. S. Olfman (Ed.).
107. Olfson M. Antipsychotic prescriptions for children and adolescents in the UK increased from 1993 to 2005. Evidence-Based Mental Health 2009, 12:30.
108. Olfson M., Crystal S., Huang C., Gerhard T. Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:13-23.
109. Olfson M., Marcus S.C., Weissman M.M. National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:514-521.
110. Oosterman M., Schuengel C., Wim Slot N., Bullens R.A.R., Doreleijers T.A.H. Disruptions in foster care: A review and meta-analysis. Children & Youth Services Review 2007, 29:53-76.
111. Palmer S.E. Placement stability and inclusive practice in foster care: An empirical study. Children & Youth Services Review 1996, 18:589-601.
112. Parens E., Johnston J. Mental health in children and adolescents. From birth to death and bench to clinic: The Hastings center bioethics briefing book for journalists, policymakers, and campaigns 2008, 101-106. The Hastings Center, Garrison, NJ. M. Crowley (Ed.).
113. Parens E., Johnston J. Understanding the agreements and controversies surrounding childhood psychopharmacology. Focus 2008, 6:322-330.
114. Pecora P.J. Why current and former recipients of foster care need high quality mental health services. Administration and Policy in Mental Health and Mental Health Services Research 2010, 37(1-2):185-190.
115. Pecora P.J., Williams J., Kessler R.C., Downs A.C., O'Brien K., Hirpi E., et al. Assessing the effects of foster care: Early results from the Casey national alumni study 2003, Casey Family Programs, Seattle, WA.
116. Persi J., Sisson M. Children in foster care: Before, during, and after psychiatric hospitalization. Child Welfare 2008, 87:79-99.
117. Pescosolido B.A., Perry B.L., Martin J.K., McLeod J.D., Jensen P.S. Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. Psychiatric Services 2007, 58(5):613.
118. Pettigrew A.M. Management research after modernism. British Journal of Management 2001, 12:S61.
119. Quinn D.M. Concealable versus conspicuous stigmatized identities. Stigma and group inequality: Social psychological perspectives 2006, 83-104. Erlbaum Associates, New York. S. Levin, C. van Laar (Eds.).
120. Rabinow P. Studies in the anthropology of reason. Anthropology Today 1992, 8:7-10.
121. Rabinow P. Essays on the anthropology of reason 1996, Princeton University Press.
122. Rabinow P., Rose N. Biopower today. Biosocieties 2006, 1:195.
123. Raghavan R., Zima B.T., Andersen R.M., Leibowitz A.A., Schuster M.A., Landsverk J. Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology 2005, 15:97-106.
124. Ridge T., Millar J. Excluding children: Autonomy, friendship and the experience of the care system. Social Policy & Administration 2000, 34:160-175.
125. Risør M. Illness behavior and functional somatic symptoms: Rethinking the concept of illness behavior from an anthropological perspective. Social Theory & Health 2006, 4(2):180-201.
126. Risør M. Illness explanations among patients with medically unexplained symptoms: Different idioms for different contexts. Health 2009, 13:505-521.
127. Roberts R., Rodriguez W., Murphy D., Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. Journal of the American Medical Association 2003, 290:905-911.
128. Rose N. The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century 2006, Princeton University Press.
129. Rose N. Beyond medicalisation. Lancet 2007, 369:700-702.
130. Rubin D.M., Alessandrini E.A., Feudtner C., Localio A.R., Hadley T. Placement changes and emergency department visits in the first year of foster care. Pediatrics 2004, 114:e354-e360.
131. Safer D.J., Zito J.M. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: Children versus adolescents. Journal of Child and Adolescent Psychopharmacology 2006, 16:159-169.
132. Safer D.J., Zito J.M., Dos Reis S. Concomitant psychotropic medication for youths. The American Journal of Psychiatry 2003, 160(3):438-449.
133. Samuels G.M. A reason, a season, or a lifetime: Relational permanence among young adults with foster care backgrounds 2008, University of Chicago, IL, Chapin Hall.
134. Sayer R.A. Method in social science: A realist approach 1992, Routledge, London. 2nd ed.
135. Shin S.H. Need for and actual use of mental health service by adolescents in the child welfare system. Children & Youth Services Review 2005, 27:1071-1083.
136. Smith D.K., Stormshak E., Chamberlain P., Whaley R.B. Placement disruption in treatment foster care. Journal of Emotional & Behavioral Disorders 2001, 9:200-205.
137. Staff I., Fein E. Stability and change: Initial findings in a study of treatment foster care placements. Children & Youth Services Review 1995, 17:379-389.
138. Starkey K., Madan P. Bridging the relevance gap: Aligning stakeholders in the future of management research. British Journal of Management 2001, 12:S3.
139. Stern L., Kirmayer L. Knowledge structures in illness narratives: Development and reliability of a coding scheme. Transcultural Psychiatry 2004, 41(1):130-142.
140. Stott T., Gustavsson N. Balancing permanency and stability for youth in foster care. Children & Youth Services Review 2010, 32:619-625.
141. Stovall-McClough K., Dozier M. Forming attachments in foster care: Infant attachment behaviors during the first 2 months of placement. Development and Psychopathology 2004, 16(2):253-271.
142. Sullivan M.J., Jones L., Mathiesen S. School change, academic progress, and behavior problems in a sample of foster youth. Children & Youth Services Review 2009, 32:164-170.
143. Testimony on behalf of the American Academy of Pediatrics to Subcommittee on Income Security and Family Support of the House Ways and Means: Hearing on the use of psychotropic medication for children in foster care, 110th Cong 2008, (testimony of Leslie, L. K.). Retrieved from http://www.aap.org/fostercare/PDFs/05-08-08%20Leslie%20psychotropics%20meds%20testimony.pdf.
144. Tex. H.B. 2163, 80 Tex. Code Section 531.0731 (2009).
145. Texas Department of State Health Services Psychotropic medication utilization parameters for foster children 2007, Retrieved from http://www.dshs.state.tx.us/mhprograms/pdf/PsychotropicMedicationUtilizationParametersFosterChildren.pdf.
146. Thomas C.P., Conrad P., Casler R., Goodman E. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatric Services 2006, 57:63-69.
147. Townsend L., Floersch J., Findling R.L. The conceptual adequacy of the drug attitude inventory for measuring youth attitudes toward psychotropic medications: A mixed methods evaluation. Journal of Mixed Methods Research 2010, 4:32-55.
148. Tranfield D., Starkey K. The nature, social organization and promotion of management research: Towards policy. British Journal of Management 1998, 9:341-353.
149. Trupin E.W., Tarico V.S., Low B.P., Jemelka R., McClellan J. Children on child protective service caseloads: Prevalence and nature of serious emotional disturbance. Child Abuse & Neglect 1993, 17:345-355.
150. Unrau Y.A., Selta J.R., Putney K.S. Former foster youth remember multiple placement moves: A journey of loss and hope. Children & Youth Services Review 2008, 30:265-273.
151. US Government Accountability Office Child Welfare: Improving Social Service Program, Training, and Technical Assistance Information Would Help Address Long-Standing Service-Level and Workforce Challenges 2006, US GAO, Washington, DC.
152. Usher C.L., Randolph K.A., Gogan H.C. Placement patterns in foster care. The Social Service Review 1999, 73:22-36.
153. Van de Ven A. Engaged Scholarship: A Guide for Organizational and Social Research 2007, Oxford University Press, Oxford.
154. Van De Ven A.H., Johnson P.E. Knowledge for theory and practice. Academy of Management Review 2006, 31:802-821.
155. Vitiello B., Jensen P.S. Medication development and testing in children and adolescents: Current problems, future directions. Archives of General Psychiatry 1997, 54:871-876.
156. Walkup J., Bernet W., Bukstein O., Walter H., Arnold V., Benson R.S., et al. Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:961-973.
157. Walth B., Cole M. Foster children's medications get little official attention. The Oregonian 2007, November 25, Retrieved from http://www.oregonlive.com/health/index.ssf/2007/11/foster_childrens_medications_g.html.
158. Ward H. Patterns of instability: Moves within the care system, their reasons, contexts and consequences. Children & Youth Services Review 2009, 31:1113-1118.
159. Webb S.A. Some considerations on the validity of evidence-based practice in social work. British Journal of Social Work 2001, 31(1).
160. Weisner T.S., Matheson C., Coots J., Bernheimer L.P. Sustainability of daily routines as a family outcome. Learning in cultural context: Family, peers, and school 2005, 41-74. Springer, New York. A. Maynard, M.I. Martini (Eds.).
161. Wells K.B. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. The American Journal of Psychiatry 1999, 156:5-10.
162. White C. Explaining a complex disease process: Talking with patients about Hansen's disease (leprosy). Medical Anthropology Quarterly 2005, 19(3):310-330.
163. Wilson D. Poor children likelier to get antipsychotics. New York Times 2009, September 11, Retrieved from http://www.nytimes.com/2009/12/12/health/12medicaid.html?_r=3&pagewanted=all.
164. Wohlfarth T., Kalverdijk L., Rademaker C., Schothorst P., Minderaa R., Gispen-de Wied C. Psychopharmacology for children: From off label use to registration. European Neuropsychopharmacology 2009, 19:603-608.
165. Zima B.T., Bussing R., Crecelius G.M., Kaufman A., Belin T.R. Psychotropic medication treatment patterns among school-aged children in foster care. Journal of Child and Adolescent Psychopharmacology 1999, 9:135-147.
166. Zima B.T., Bussing R., Crecelius G.M., Kaufman A., Belin T.R. Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. American Journal of Public Health 1999, 89(11):1732-1735.
167. Zito J.M., Derivan A.T., Kratochvil C.J., Safer D.J., Fegert J.M., Greenhill L.L. Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health 2008, 2:24.
168. Zito J.M., Safer D.J. Antidepressant treatment in children and adolescents: Bridging the gap between efficacy and effectiveness. Current Psychiatry Reports 2001, 3(2):115-125.
169. Zito J.M., Safer D.J., DosReis S., Gardner J.F., Magder L., Soeken K., et al. Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics & Adolescent Medicine 2003, 157(1):17.
170. Zito J.M., Safer D.J., Sai D., Gardner J.F., Thomas D., Coombes P., et al. Psychotropic medication patterns among youth in foster care. Pediatrics 2008, 121:E157-E163.
171. Zito J.M., Safer D.J., Valluri S., Gardner J.F., Korelitz J.J., Mattison D.R. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology 2007, 17:195-204.
172. Zito J.M., Safer D.J., Zuckerman I.H., Gardner J.F., Soeken K. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services 2005, 56:157-163.
173. Zito J.M., Socolar S.J., Eilers R., Crystal S., Lexchin J. Regulating drugs for effectiveness and safety: A public health perspective. Medical Care 2007, 45(9):911. 10.1097/MLR.0b013e31810377af.